Pharmaceuticals company Divi's Laboratories announced Q3FY25 results Consolidated total income Rs 2,401 crore for Q3FY25 as against a consolidated total income of Rs 1,950 crore for Q3FY24. Profit before tax (PBT) for Q3FY25 amounted to Rs 726 crore as against a PBT of Rs 489 crore for Q3FY24. Profit after tax (PAT) for Q3FY25 amounted to Rs 589 crore as against a PAT of Rs 358 crore for Q3FY24. For the Q3FY25, we have forex gain of Rs 10 crore as against a gain of Rs 18 crore during Q3FY24. Result PDF